A Physical Activity Program in End-state Liver Disease

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 31, 2020

Study Completion Date

June 30, 2020

Conditions
End-stage Liver Disease (ESLD)Liver TransplantSarcopeniaPoor Physical FitnessCirrhosisPortal Hypertension
Interventions
OTHER

Nutritional consultation

Dietary advice will be provided at the beginning of the study and individually tailored to the participant's usual eating habits plus amino acid supplement including 10 grams of branched-chain amino acids

BEHAVIORAL

Physical training program

Physical activity prescription will target ≥10,000 steps/day, taking into account all activities performed throughout the day, although the increment in activity should be no less than 3000 steps/day above the baseline.

BEHAVIORAL

Behavioral modification therapy

The behavior modification theory will be applied in the form of a structured set of cues and questions between investigator and participant at each visit in order to provide individually tailored counseling to enhance internal motivation and facilitate behavior change toward physical activity and dietary improvement that are adaptable to each participant's usual habits.

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT02776553 - A Physical Activity Program in End-state Liver Disease | Biotech Hunter | Biotech Hunter